Our funding sources

Current funding agencies (since 2018)

Acknowledgement of past support:

2016 – 2019           HFSP fellowship LT000216 (S. Fortier, postdoc)

2015 – 2017           Swiss National Science Foundation, 31003A_156452

2014 – 2017           Gebert-Rüf Stiftung – Rare Diseases GRS-051/13

2014 – 2016           Stiftung für Wissenschaftliche Forschung, Zürich

2013 – 2015           ISREC foundation (4 year PhD student fellowship)

2011 – 2014           Swiss National Science Foundation, 31003A-135615

2010 – 2013           Swiss National Science Foundation, Sinergia CRSI33_130662

2009 – 2012           Swiss Cancer League, KFS 02487-08-2009

2008 – 2011           Merck-Serono, strategic collaboration

2007 – 2010           Swiss National Science Foundation, 3100A0-118080 / 1

2007 – 2008           American PKD foundation

2006 – 2009           EU STREP, 6th Framework Program

2006 – 2009           OPO Stiftung

2004 – 2007           Swiss National Science Foundation, 3100A0-105583 /1

2003 – 2006           Swiss Cancer League, OCS-01301-02-2003

2004                       Pfizer Inc., Strategic Collaboration

2001 – 2004           Swiss National Science Foundation, 3100-062031.00/1

2001 – 2003           HFSP fellowship (A. Le Good, postdoc)

2001 – 2004           Swiss Cancer League, SKL 1101-02-2001